Driving clinical trial speed and compliance
With the higher volumes of data that exist in today’s accelerated clinical trials, having an Interactive Response Technology (IRT) partner who understands the challenges of managing this data and how to properly support a regulatory submission is critical.
As the go-to partner for complex studies, Almac Clinical Technologies was the first-ever IRT provider to be audited by the FDA in support of a client’s submission. This article, which is avaiable on Almac Clinical University, will reveal what FDA auditors recognised as the catalyst for reducing trial issues and improving control and predictability.
Almac Diagnostics launch new website – complimentary webinar download
Almac Diagnostics recently launched its new website highlighting its unique Customised Companion Diagnostics (CDx) approach for Pharma and Biotech companies. The website has a wide range of new content on Almac Diagnostic's CDx capabilities, state-of-the art laboratories & platforms and specialist supporting services. There is also a bespoke section detailing its R&D product pipeline of both predictive and prognostic assays.
We are also pleased to announce that Almac Diagnostic's latest Webinar on ‘Next Generation Sequencing Panels – From patient selection to CDx’, by Dr Cheryl McFarlane, Operations Manager, is available to download now.
Webinar Highlights: